| Source HCPCS Code |
|
Target NDC Code |
90291
Cytomegalovirus immune globulin (CMV-IgIV), human, for intravenous use
|
⇄
|
49591-0532-50
CYTOGAM 2.5 GM/50 ML VIAL
|
| Detail Information |
| Relationship Start Date |
10/11/2023 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
50 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
90291
Cytomegalovirus immune globulin (CMV-IgIV), human, for intravenous use
|
⇄
|
49591-0532-51
CYTOGAM 2.5 GM/50 ML VIAL
|
| Detail Information |
| Relationship Start Date |
10/11/2023 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
50 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
90291
Cytomegalovirus immune globulin (CMV-IgIV), human, for intravenous use
|
⇄
|
70257-0532-50
CYTOGAM 2.5 GM/50 ML VIAL
|
| Detail Information |
| Relationship Start Date |
07/01/2022 |
| Relationship End Date |
01/10/2024 |
| Number Of Items In Ndc Package |
50 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
90291
Cytomegalovirus immune globulin (CMV-IgIV), human, for intravenous use
|
⇄
|
70257-0532-51
CYTOGAM 2.5 GM/50 ML VIAL
|
| Detail Information |
| Relationship Start Date |
04/27/2017 |
| Relationship End Date |
01/10/2024 |
| Number Of Items In Ndc Package |
50 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|